CPT code 17272 represents the destruction of a malignant cutaneous lesion measuring 1.1 cm to 2.0 cm in diameter using methods such as chemosurgery, cryosurgery, electrosurgery, or other destructive techniques. This code is used nationally for billing ambulatory procedures performed on anatomically sensitive or functional areas including the scalp, neck, hands, feet, and genitalia. Accurate use of this code affects clinical documentation, procedural coding consistency, and payment for dermatologic and minor surgical services.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides benchmarks on utilization and allowed amounts where available, highlights relevant policy and coverage updates affecting lesion destruction services, and summarizes the clinical context for lesion size and anatomic site that drive code selection.

Readers will learn how CPT code 17272 is defined and applied in ambulatory and outpatient settings, common coding considerations tied to lesion size and location, and what payers typically evaluate when adjudicating claims for malignant lesion destruction. The summary includes national-level insights into coding practice and policy trends that influence reimbursement and documentation standards. Data not available in the input is noted where applicable.